Citadel Advisors’s PACS Group PACS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Buy
85,100
+39,300
+86% +$1.41M ﹤0.01% 5304
2026
Q1
$1.47M Sell
45,800
-56,800
-55% -$2.09M ﹤0.01% 6755
2025
Q4
$3.94M Buy
102,600
+70,100
+216% +$1.54M ﹤0.01% 4685
2025
Q3
$446K Sell
32,500
-22,000
-40% -$258K ﹤0.01% 9420
2025
Q2
$704K Sell
54,500
-477,500
-90% -$4.96M ﹤0.01% 7825
2025
Q1
$5.98M Buy
532,000
+499,100
+1,517% +$6.55M ﹤0.01% 3602
2024
Q4
$431K Buy
32,900
+27,600
+521% +$708K ﹤0.01% 8890
2024
Q3
$212K Sell
5,300
-600
-10% -$21.8K ﹤0.01% 10024
2024
Q2
$174K Buy
+5,900
New +$161K ﹤0.01% 10133

Other funds holding PACS

Citadel Advisors's PACS Position: Q2 2026 in Review

Citadel Advisors reduced its PACS Group (PACS) stake by 77% in Q2 2026, selling an estimated $16.9M and leaving 144,242 shares worth $6.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4371.

Citadel Advisors first reported a position in PACS in Q2 2024 and has held it in 9 quarters since. The position peaked at $25.2M in Q2 2024. 239 funds tracked by Wall St. Rank hold PACS as of Q2 2026.

  • Citadel Advisors held 144,242 shares of PACS Group worth $6.15M as of Q2 2026.
  • Citadel Advisors sold 470,572 PACS Group shares in Q2 2026, an estimated $16.9M.
  • PACS Group made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4371 holding.
  • Citadel Advisors first reported a position in PACS Group in Q2 2024 and has held it in 9 quarters since.
  • Citadel Advisors's PACS Group position peaked at $25.2M in Q2 2024.
  • 239 funds tracked by Wall St. Rank held PACS Group as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.